Novolog (Pharm-Up 1966) Ltd (NVLG.TA)
ILA 155.0
(2.85%)
ILA 155.0
(2.85%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 2.65 Million ILS | -96.63% |
| 2022 | 78.77 Million ILS | 12.64% |
| 2021 | 69.93 Million ILS | 14.47% |
| 2020 | 61.09 Million ILS | 84.79% |
| 2019 | 33.06 Million ILS | 5.32% |
| 2018 | 31.39 Million ILS | 2.3% |
| 2017 | 30.68 Million ILS | -22.72% |
| 2016 | 39.71 Million ILS | 8.81% |
| 2015 | 36.49 Million ILS | 3.17% |
| 2014 | 35.37 Million ILS | 50.16% |
| 2013 | 23.55 Million ILS | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 20.43 Million ILS | 154.53% |
| 2024 Q2 | 17.19 Million ILS | -15.87% |
| 2023 FY | 2.65 Million ILS | -96.63% |
| 2023 Q1 | 21.56 Million ILS | -84.21% |
| 2023 Q4 | -37.48 Million ILS | -1406.47% |
| 2023 Q2 | 17.03 Million ILS | -21.0% |
| 2023 Q3 | -2.48 Million ILS | -114.61% |
| 2022 Q1 | 20.65 Million ILS | -83.25% |
| 2022 FY | 78.77 Million ILS | 12.64% |
| 2022 Q4 | 136.53 Million ILS | 835.03% |
| 2022 Q3 | -18.57 Million ILS | -200.26% |
| 2022 Q2 | 18.52 Million ILS | -10.32% |
| 2021 Q3 | -17.3 Million ILS | -202.17% |
| 2021 FY | 69.93 Million ILS | 14.47% |
| 2021 Q2 | 16.93 Million ILS | -11.59% |
| 2021 Q1 | 19.15 Million ILS | 32.86% |
| 2021 Q4 | 123.33 Million ILS | 812.74% |
| 2020 Q3 | 15.05 Million ILS | 13.46% |
| 2020 Q1 | 18.34 Million ILS | 93.96% |
| 2020 Q2 | 13.27 Million ILS | -27.65% |
| 2020 FY | 61.09 Million ILS | 84.79% |
| 2020 Q4 | 14.41 Million ILS | -4.24% |
| 2019 Q2 | 9.22 Million ILS | -16.32% |
| 2019 FY | 33.06 Million ILS | 5.32% |
| 2019 Q4 | 9.45 Million ILS | 402.23% |
| 2019 Q3 | 1.88 Million ILS | -79.58% |
| 2019 Q1 | 11.02 Million ILS | 58.79% |
| 2018 Q1 | 8.63 Million ILS | 34.99% |
| 2018 FY | 31.39 Million ILS | 2.3% |
| 2018 Q4 | 6.94 Million ILS | -8.95% |
| 2018 Q3 | 7.62 Million ILS | -7.03% |
| 2018 Q2 | 8.19 Million ILS | -5.02% |
| 2017 Q2 | 7.86 Million ILS | -8.43% |
| 2017 Q3 | 7.84 Million ILS | -0.27% |
| 2017 FY | 30.68 Million ILS | -22.72% |
| 2017 Q4 | 6.39 Million ILS | -18.46% |
| 2017 Q1 | 8.58 Million ILS | 39.08% |
| 2016 Q1 | 11.94 Million ILS | 116.71% |
| 2016 Q4 | 6.17 Million ILS | -36.68% |
| 2016 FY | 39.71 Million ILS | 8.81% |
| 2016 Q3 | 9.75 Million ILS | -17.65% |
| 2016 Q2 | 11.83 Million ILS | -0.9% |
| 2015 FY | 36.49 Million ILS | 3.17% |
| 2015 Q3 | 6.58 Million ILS | 0.0% |
| 2015 Q4 | 5.51 Million ILS | -16.23% |
| 2014 FY | 35.37 Million ILS | 50.16% |
| 2013 FY | 23.55 Million ILS | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|